Vici P - Search Results

1

Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patient.

Pizzuti L, Sergi D, Barba M, Vici P. Pizzuti L, et al. Among authors: vici p. Tumori. 2013 May-Jun;99(3):e127-30. doi: 10.1177/030089161309900332. Tumori. 2013. PMID: 24158082

2

[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].

Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M. Conti F, et al. Among authors: vici p. Clin Ter. 2007 Jul-Aug;158(4):331-41. Clin Ter. 2007. PMID: 17953285 Clinical Trial. Italian.

3

A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

Vici P, Di Lauro L, Sergi D, Foggi P, Viola G, Mottolese M, Giotta F, Fattoruso SI, Corsetti S, Giannarelli D, Botti C, Lopez M. Vici P, et al. Oncology. 2008;75(3-4):175-81. doi: 10.1159/000163056. Epub 2008 Oct 8. Oncology. 2008. PMID: 18841031 Clinical Trial.

4

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M. Vici P, et al. Clin Ter. 2008 Nov-Dec;159(6):449-52. Clin Ter. 2008. PMID: 19169607 Review.

5

Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

Vici P, Viola G, Rossi S, Botti C, Vitucci C, Sergi D, Ferranti FR, Saracca E, Di Lauro L, Corsetti S, Foggi P, Fattoruso SI, Lopez M. Vici P, et al. Clin Ter. 2008 Nov-Dec;159(6):453-6. Clin Ter. 2008. PMID: 19169608 Review.

6

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M. Vici P, et al. Anticancer Res. 2009 May;29(5):1841-5. Anticancer Res. 2009. PMID: 19443414 Free article. Clinical Trial.

7

Recent advances in the adjuvant treatment of early breast cancer.

De Luca C, Vici P, Carpano S, Sergi D, Viola G, Corsetti S, Toglia G, Pinnarò P, Vizza E, Amodio A, Paoletti G, Lopez M. De Luca C, et al. Among authors: vici p. Clin Ter. 2009;160(4):299-306. Clin Ter. 2009. PMID: 19795084 Review.

8

[Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].

Lopez M, Di Lauro L, Viola G, Foggi P, Conti F, Corsetti S, Sergi D, Botti C, Di Filippo F, Vici P. Lopez M, et al. Among authors: vici p. Clin Ter. 2009;160(6):481-8. Clin Ter. 2009. PMID: 20198292 Italian.

9

[Psyche and cancer].

Lopez M, Cauchi C, Sergi D, Amodio A, Paoletti G, Vici P, Di Lauro L. Lopez M, et al. Among authors: vici p. Clin Ter. 2010;161(1):69-75. Clin Ter. 2010. PMID: 20393684 Italian.

10

Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.

Vici P, Fabi A, Metro G, Sergi D, Giannarelli D, Di Lauro L, Bepler G, Tomao F, Cognetti F, Conti F, Lopez M. Vici P, et al. Cancer Chemother Pharmacol. 2011 Mar;67(3):687-93. doi: 10.1007/s00280-010-1369-y. Epub 2010 May 29. Cancer Chemother Pharmacol. 2011. PMID: 20512334 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters